Sponsor or institution
Clinical trials and research at Arcus Biosciences, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Arcus Biosciences, Inc. that are recruiting, at sites in 17 countries (most in United States (3), Australia (2), South Korea (2)). By phase: Phase 1 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 17Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Casdatifan pharmacokinetics in moderate hepatic impairment vs normal liver function | Phase 1 | San Antonio, Texas | Recruiting | Aug 7, 2026 |
| Safety and tolerability of AB102 in healthy adults | Phase 1 | Groningen | Recruiting | Jun 23, 2026 |
| Casdatifan plus cabozantinib versus placebo plus cabozantinib for advanced clear cell kidney cancer | Phase 3 | Gilbert, Arizona and 190 other locations | Recruiting | Jun 10, 2025 |
| Evaluating AB521 for kidney cancer and other solid tumors | Phase 1 | Birmingham, Alabama and 24 other locations | Recruiting | Sep 10, 2022 |
All recruiting trials (4)
-
Casdatifan pharmacokinetics in moderate hepatic impairment vs normal liver function
This study tests how a single dose of casdatifan behaves in people with moderate liver impairment compared to healthy individuals with normal liver function.
-
Safety and tolerability of AB102 in healthy adults
This study tests whether AB102 is safe and well tolerated in healthy adults and looks at how the body processes the drug after single and multiple oral doses.
-
Casdatifan plus cabozantinib versus placebo plus cabozantinib for advanced clear cell kidney cancer
This trial tests whether adding casdatifan to cabozantinib helps adults with advanced or metastatic clear cell kidney cancer who progressed after PD‑1 or PD‑L1 immunotherapy.
-
Evaluating AB521 for kidney cancer and other solid tumors
This study is testing a new treatment called casdatifan, alone and with other medications, to see if it helps people with advanced kidney cancer and other solid tumors feel better.
Quick answers
How many clinical trials run by Arcus Biosciences, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in United States (3 trials), Australia (2 trials), South Korea (2 trials), Spain (2 trials), Netherlands (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.